May 12, 2016 / 10:22 AM / in 2 years

BRIEF-Fennec qtrly loss per share $0.04

May 12 (Reuters) - Fennec Pharmaceuticals Inc :

* Qtrly loss per share $0.04

* Entered into agreement with elion oncology involving transfer by fennec of intellectual property, data relating to eniluracil

* Agreement for transfer by co of intellectual property relating to eniluracil,adh-1 technologies,development programs to elion

* Fennec provides corporate update and announces first quarter 2016 results Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below